BlackRock Institutional Trust Company, N.A. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2016$23,837,000
-44.4%
776,456
+21.3%
0.00%
-42.9%
Q3 2016$42,908,000
+147.2%
639,937
+9.8%
0.01%
+133.3%
Q2 2016$17,355,000
+1.0%
582,564
-0.4%
0.00%0.0%
Q1 2016$17,181,000
-61.6%
584,979
+2.5%
0.00%
-57.1%
Q4 2015$44,754,000
+0.6%
570,847
-3.3%
0.01%
-12.5%
Q3 2015$44,484,000
-35.3%
590,290
+0.3%
0.01%
-27.3%
Q2 2015$68,730,000
-48.8%
588,693
+3.5%
0.01%
-47.6%
Q1 2015$134,235,000
+27.7%
568,529
+2.4%
0.02%
+23.5%
Q4 2014$105,119,000
-20.4%
555,391
+0.4%
0.02%
-22.7%
Q3 2014$132,027,000
+235.2%
553,410
-7.3%
0.02%
+214.3%
Q2 2014$39,392,000
-33.4%
596,848
+5.2%
0.01%
-30.0%
Q1 2014$59,111,000
+18.4%
567,607
+17.7%
0.01%
+11.1%
Q4 2013$49,923,000
+207.6%
482,204
+59.5%
0.01%
+200.0%
Q3 2013$16,228,000
+41.9%
302,414
+17.3%
0.00%
+50.0%
Q2 2013$11,440,000257,8250.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders